API SUPPLIERS

API Suppliers

8

US DMFs Filed

4

CEP/COS Certifications

0

JDMFs Filed

0

EU WC

3

Listed Suppliers

4

API REF. PRICE (USD / KG)

9,327

API Market Place

1

INTERMEDIATES

5

DOSSIERS // FDF

USA (Orange Book)

20

Europe

2

Canada

0

Australia

0

South Africa

0

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

181.00

Annual Reports

0

FDF Market Place

1

EXCIPIENTS

152

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

14

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

13

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

List of Suppliers

Full Screen View

Reset Filter

Price Info

Inabata France S.A.S

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

France

Virtual Booth

Digital Content

2-Hydroxypyridine

PDF Supplier PDF

URL Supplier Web Content

CAS Number

142-08-5

End Use API

Established in 1990, Inabata France, a part of the Inabata Group, used to export chemical and pharmaceuti...

Established in 1990, Inabata France, a part of the Inabata Group, used to export chemical and pharmaceutical products to Japan. In 2006, it acquired Pharmasynthèse. Today, Inabata-Pharmasynthèse offers a wide range of services, including sourcing, manufacturing, and the development of raw materials for the pharmaceutical and cosmetic industries. It supplies these ingredients to Europe, Japan, and other countries. With expertise in fine chemical production, Inabata-Pharmasynthèse conducts manufacturing operations, ranging from pilot to commercial quantities, at its GMP-certified facility at St. Pierre-Les-Elbeuf in France.

Chemspec Europe 2024

Attending

envelop Contact Supplier

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

List of Suppliers of Aliskiren intermediates listed on PharmaCompass.com

Aliskiren

Aliskiren

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

8 API Suppliers

4 USDMF

3 EU WC

3 NDC API

4 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

5 Suppliers

DOSSIERs // Finished Dosage Formulations

22 Dossiers

20 FDA Orange Book

2 Europe

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 150MG BASE

TABLET;ORAL - EQ 300MG BASE

TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

22 BASF

16 Kerry

10 Roquette

10 Corel Pharma Chem

10 Microlex e.U

9 Sigachi Industries

8 Gangwal Chemicals

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Seppic

6 Lonza Capsugel

5 Boai NKY Pharmaceuticals Ltd

5 Ideal Cures Pvt Ltd

5 Gangwal Healthcare

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Actylis

3 Pharmatrans-Sanaq

3 Kima Chemical

2 Nomisma Healthcare

2 DFE Pharma

2 Prachin Chemical

2 Seqens

2 The Dow Chemical Company

2 Ulanqab Kema New Material

2 Vasa Pharmachem

1 DKSH

1 Aeon Procare

1 SPI Pharma

1 Finar

1 Alcedo Pharmachem

1 Qianhao Chemical (Hebei) Co., Ltd

1 ACG Worldwide

1 Qualicaps

EXCIPIENTS BY APPLICATIONS

42 Coating Systems & Additives

32 Fillers, Diluents & Binders

28 Controlled & Modified Release

22 Direct Compression

21 Disintegrants & Superdisintegrants

18 Thickeners and Stabilizers

17 Granulation

14 Solubilizers

13 Lubricants & Glidants

8 Film Formers & Plasticizers

8 Co-Processed Excipients

7 Topical

6 Chewable & Orodispersible Aids

5 Empty Capsules

4 Parenteral

4 Vegetarian Capsules

4 API Stability Enhancers

TABLET;ORAL - EQ 150MG BASE;12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 150MG BASE;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 300MG BASE;12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 300MG BASE;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons